Microfluidics Market Size, Share, Growth Analysis, By Product (Microfluidics-based Device, Microfluidic Components), By Material (Glass, Silicon), By Application (In Vitro Diagnostics, Therapeutics), By End User (Hospital and Diagnostic Centers, Academic and Research Institute), By Region - Industry Forecast 2024-2031

Global Microfluidics Market size was valued at USD 21.70 billion in 2022 and is poised to grow from USD 24.48 billion in 2023 to USD 64.16 billion by 2031, growing at a CAGR of 12.8% during the forecast period (2024-2031).

It takes fewer samples and smaller instruments than conventional fluid measuring equipment, and it offers superior parameter control and data quality. It is therefore frequently employed in PCR amplification, cell separation, and DNA analysis. According to a study that appeared in PLOS One in January, France is anticipated to have roughly 2.8 million cases of chronic obstructive pulmonary disease (COPD) by 2025. This is projected to promote the market's growth by increasing demand for COPD testing using microfluidic chips and tiny blood samples. According to Dementia Australia's 2022 statistics, there will be 487,500 Australians living with dementia in that country in 2022, and by 2058, that number is expected to rise to 1.1 million. Therefore, there is a greater need for efficient medication discovery, screening techniques, and toxicological investigations as dementia rates among the target group rise. This increases the need for microfluidics systems that can be utilised to develop skeletal, glial, and endothelial cells, providing a chance to look at organogenesis and illness aetiology while maintaining fluid isolation of muscle cells. The market is anticipated to be driven by the growing use of microfluidics devices in various areas of research and diagnosis.

US Microfluidics Market is poised to grow at a sustainable CAGR for the next forecast period.